Meibomian Gland

There are many different types of dry eye disease clinics in North America. No matter what type of practice you might have, it is highly likely that practicing your subspecialty became measurably easier in 2023.

ATLANTA —There is limited evidence to show that LipiFlow is more effective than commonly used treatments for dry eye disease and meibomian gland dysfunction, according to recently published research.

In dry eye care, 2023 was a year of substantial changes, and ophthalmologists and their patients have welcomed more treatment options that bring relief.

There is an old saying — it might even be true — that medical students who go into psychiatry do so to figure out what is wrong with them.

The office-based thermal eyelid treatment TearCare significantly improved tear breakup time and measures of meibomian gland secretion compared with Restasis in patients with dry eye disease, according to 6-month trial data.

There is simply no other way to put this: Miebo is magic.

NEW ORLEANS — New research in dry eye disease suggests the next few years will bring significant advancements in treatment for patients, according to a speaker at Academy ’23.

I talk about cosmetics every day with my patients, and most patients mention that I’m the first eye doctor to raise the subject.

Controlled heat therapy in combination with manual meibomian gland expression reduced signs and symptoms of meibomian gland dysfunction for 12 months, according to a study published in Optometry and Vision Science.

Presurgical treatment with LipiFlow improved meibomian gland function in patients with range of vision IOLs, according to a study.